FARLEY CAPITAL L.P. historic quarter change: USA Other Stocks, Added
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, FARLEY CAPITAL L.P. opened 13 positions, added to 36, reduced 27 and sold out of 15.
- Q3 2016: Stock CTRIP COM INTL LTD; Country of operation —; Class AMERICAN DEP SHS; Shares before 34,850.
- Q2 2016: Stock DEVRY ED GROUP INC; Country of operation —; Class COM; Shares before 1,634,758.
- Q1 2016: Stock VALEANT PHARMACEUTICALS INTL; Country of operation —; Class COM; Shares before 222,282.
- Q1 2016: Stock DEVRY ED GROUP INC; Country of operation —; Class COM; Shares before 1,322,439.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1479465), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-06); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-11); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-12); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-07-30); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-14); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-12); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-13); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-06); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-13); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-13); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-12); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-14); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-13); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-13); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-13); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-13); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-07). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2012-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | CTRIP COM INTL LTD
CUSIP 22943F100 | | AMERICAN DEP SHS | 34,850 | 40,092 | +5,242 | $1,436,000 | $1,867,000 | +$431,000 | 2016-11-14 |
|---|
| Q2 2016 | DEVRY ED GROUP INC
CUSIP 251893103 | | COM | 1,634,758 | 1,715,758 | +81,000 | $28,232,000 | $30,609,000 | +$2,377,000 | 2016-08-15 |
|---|
| Q1 2016 | VALEANT PHARMACEUTICALS INTL
CUSIP 91911K102 | | COM | 222,282 | 307,458 | +85,176 | $22,595,000 | $8,086,000 | -$14,509,000 | 2016-05-13 |
|---|
| Q1 2016 | DEVRY ED GROUP INC
CUSIP 251893103 | | COM | 1,322,439 | 1,634,758 | +312,319 | $33,471,000 | $28,232,000 | -$5,239,000 | 2016-05-13 |
|---|
| Q1 2016 | LUXOFT HLDG INC
CUSIP G57279104 | | ORD SHS CL A | 11,719 | 55,869 | +44,150 | $904,000 | $3,074,000 | +$2,170,000 | 2016-05-13 |
|---|
| Q1 2016 | SYMANTEC CORP
CUSIP 871503108 | | COM | 9,560 | 86,088 | +76,528 | $201,000 | $1,582,000 | +$1,381,000 | 2016-05-13 |
|---|
| Q4 2015 | VALEANT PHARMACEUTICALS INTL
CUSIP 91911K102 | | COM | 192,130 | 222,282 | +30,152 | $34,272,000 | $22,595,000 | -$11,677,000 | 2016-02-16 |
|---|
| Q4 2015 | ALLERGAN PLC
CUSIP G0177J108 | | SHS | 9,400 | 11,146 | +1,746 | $2,555,000 | $3,483,000 | +$928,000 | 2016-02-16 |
|---|
| Q3 2015 | VALEANT PHARMACEUTICALS INTL
CUSIP 91911K102 | | COM | 141,020 | 192,130 | +51,110 | $31,328,000 | $34,272,000 | +$2,944,000 | 2015-11-13 |
|---|
| Q3 2015 | LUXOFT HLDG INC
CUSIP G57279104 | | ORD SHS CL A | 68,292 | 87,221 | +18,929 | $3,862,000 | $5,520,000 | +$1,658,000 | 2015-11-13 |
|---|
| Q3 2015 | DEVRY ED GROUP INC
CUSIP 251893103 | | COM | 1,349,305 | 1,503,009 | +153,704 | $40,452,000 | $40,897,000 | +$445,000 | 2015-11-13 |
|---|
| Q3 2015 | SYMANTEC CORP
CUSIP 871503108 | | COM | 19,700 | 29,560 | +9,860 | $458,000 | $576,000 | +$118,000 | 2015-11-13 |
|---|
| Q2 2015 | DEVRY ED GROUP INC
CUSIP 251893103 | | COM | 1,058,187 | 1,349,305 | +291,118 | $35,301,000 | $40,452,000 | +$5,151,000 | 2015-08-12 |
|---|
| Q2 2015 | SYMANTEC CORP
CUSIP 871503108 | | COM | 12,000 | 19,700 | +7,700 | $280,000 | $458,000 | +$178,000 | 2015-08-12 |
|---|
| Q2 2015 | MONSANTO CO
CUSIP 61166W101 | | COM | 82,692 | 88,692 | +6,000 | $9,306,000 | $9,454,000 | +$148,000 | 2015-08-12 |
|---|
| Q1 2015 | DEVRY ED GROUP INC
CUSIP 251893103 | | COM | 577,975 | 1,058,187 | +480,212 | $27,436,000 | $35,301,000 | +$7,865,000 | 2015-05-14 |
|---|
| Q1 2015 | NEUSTAR INC
CUSIP 64126X201 | | CL A | 229,665 | 263,165 | +33,500 | $6,385,000 | $6,479,000 | +$94,000 | 2015-05-14 |
|---|
| Q4 2014 | JACOBS ENGR GROUP INC DEL
CUSIP 469814107 | | COM | 8,000 | 113,599 | +105,599 | $439,000 | $5,077,000 | +$4,638,000 | 2015-02-13 |
|---|
| Q4 2014 | GOOGLE INC
CUSIP 38259P706 | | CL C | 28,339 | 28,359 | +20 | $16,362,000 | $14,928,000 | -$1,434,000 | 2015-02-13 |
|---|
| Q3 2014 | MONSANTO CO
CUSIP 61166W101 | | COM | 16,470 | 136,013 | +119,543 | $2,054,000 | $15,303,000 | +$13,249,000 | 2014-11-13 |
|---|
| Q3 2014 | VALEANT PHARMACEUTICALS INTL
CUSIP 91911K102 | | COM | 333,081 | 341,518 | +8,437 | $42,008,000 | $44,807,000 | +$2,799,000 | 2014-11-13 |
|---|
| Q3 2014 | NEUSTAR INC
CUSIP 64126X201 | | CL A | 176,642 | 241,244 | +64,602 | $4,596,000 | $5,990,000 | +$1,394,000 | 2014-11-13 |
|---|
| Q3 2014 | GOOGLE INC
CUSIP 38259P706 | | CL C | 28,330 | 28,339 | +9 | $16,298,000 | $16,362,000 | +$64,000 | 2014-11-13 |
|---|
| Q2 2014 | VALEANT PHARMACEUTICALS INTL
CUSIP 91911K102 | | COM | 277,812 | 333,081 | +55,269 | $36,624,000 | $42,008,000 | +$5,384,000 | 2014-08-14 |
|---|
| Q2 2014 | PRAXAIR INC
CUSIP 74005P104 | | COM | 41,818 | 41,895 | +77 | $5,477,000 | $5,565,000 | +$88,000 | 2014-08-14 |
|---|
| Q1 2014 | VALEANT PHARMACEUTICALS INTL
CUSIP 91911K102 | | COM | 247,121 | 277,812 | +30,691 | $29,012,000 | $36,624,000 | +$7,612,000 | 2014-05-13 |
|---|
| Q1 2014 | NEUSTAR INC
CUSIP 64126X201 | | CL A | 295,516 | 305,642 | +10,126 | $14,734,000 | $9,936,000 | -$4,798,000 | 2014-05-13 |
|---|
| Q1 2014 | GOOGLE INC
CUSIP 38259P508 | | CL A | 27,558 | 28,221 | +663 | $30,885,000 | $31,453,000 | +$568,000 | 2014-05-13 |
|---|
| Q1 2014 | PRAXAIR INC
CUSIP 74005P104 | | COM | 40,791 | 41,818 | +1,027 | $5,304,000 | $5,477,000 | +$173,000 | 2014-05-13 |
|---|
| Q4 2013 | NEUSTAR INC
CUSIP 64126X201 | | CL A | 205,836 | 295,516 | +89,680 | $10,185,000 | $14,734,000 | +$4,549,000 | 2014-02-13 |
|---|
| Q3 2013 | NEUSTAR INC
CUSIP 64126X201 | | CL A | 66,580 | 205,836 | +139,256 | $3,241,000 | $10,185,000 | +$6,944,000 | 2013-11-07 |
|---|
| Q3 2013 | VALEANT PHARMACEUTICALS INTL
CUSIP 91911K102 | | COM | 246,856 | 247,121 | +265 | $21,249,000 | $25,782,000 | +$4,533,000 | 2013-11-07 |
|---|
| Q3 2013 | GOOGLE INC
CUSIP 38259P508 | | CL A | 25,283 | 27,558 | +2,275 | $22,258,000 | $24,138,000 | +$1,880,000 | 2013-11-07 |
|---|
| Q3 2013 | PRAXAIR INC
CUSIP 74005P104 | | COM | 27,800 | 40,791 | +12,991 | $3,201,000 | $4,903,000 | +$1,702,000 | 2013-11-07 |
|---|
| Q3 2013 | MONSANTO CO NEW
CUSIP 61166W101 | | COM | 26,039 | 29,169 | +3,130 | $2,573,000 | $3,044,000 | +$471,000 | 2013-11-07 |
|---|
| Q3 2013 | DEVRY INC DEL
CUSIP 251893103 | | COM | 938,887 | 950,575 | +11,688 | $29,124,000 | $29,050,000 | -$74,000 | 2013-11-07 |
|---|